Ercan Karaarslan

Ercan Karaarslan

Auto-generated profile, based on publicly available information

Ercan Karaarslan

Acibadem Mehmet Ali Aydinlar University, School of Medicine, Department of Radiology, Istanbul, Turkey

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2020 in Radiology
Verified
Journal Article
Closed access
SKSedat G. Kandemirli
Sedat G. Kandemirli
LDLerzan Dogan
Lerzan Dogan
ZSZeynep Tugce Sarikaya
Zeynep Tugce Sarikaya
SKSimay Kara
Simay Kara
CACanan Akinci
Canan Akinci
NKNaci Kocer
Naci Kocer
Online supplemental material is available for this article.

1 March 2008 in European Journal of Radiology
Verified
Journal Article
Closed access
EKE. Karaarslan
E. Karaarslan
AAA. Arslan
A. Arslan

13 January 2010 in American Journal of Neuroradiology
Verified
Journal Article
Open access
PDF file
EKE. Karaarslan
E. Karaarslan
SUS. Ulus
S. Ulus
MKM. Kürtüncü
M. Kürtüncü
SUMMARY: We report 2 patients with migraine with aura, in whom SWI showed transient prominence of the venous vasculature within areas of impaired perfusion. The findings resolved spontaneously in both patients. This imaging technique may play a helpful role in assessing the vascular events in migraine with aura.

11 June 2023 in European Journal of Radiology
Verified
Journal Article
Closed access
DADeniz Can Aliş
Deniz Can Aliş
MKMustafa Said Kartal
Mustafa Said Kartal
MSMustafa Ege Seker
Mustafa Ege Seker
BGBatuhan Guroz
Batuhan Guroz
YBYeliz Basar
Yeliz Basar
EKErcan Karaarslan
Ercan Karaarslan

29 April 2024 in Diagnostic and Interventional Radiology
Verified
Journal Article
Open access
DADeniz Can Aliş
Deniz Can Aliş
TTToygar Tanyel
Toygar Tanyel
EMEmine Meltem
Emine Meltem
Mustafa Ege SekerMustafa Ege Seker
Mustafa Ege Seker
DSDelal Seker
Delal Seker
IÖİlKay Öksüz
İlKay Öksüz
The rapid evolution of artificial intelligence (AI), particularly in deep learning, has significantly impacted radiology, introducing an array of AI solutions for interpretative tasks. This paper provides radiology departments with a practical guide for selecting and integrating AI solutions, focusing on interpretative tasks that require the active involvement of radiologists. Our approach is not to list available applications or review scientific evidence, as this information is readily available in previous studies; instead, we concentrate on the essential factors radiology departments must consider when choosing AI solutions. These factors include clinical relevance, performance and validation, implementation and integration, clinical usability, costs and return on investment, and regulations, security, and privacy. We illustrate each factor with hypothetical scenarios to provide a clearer understanding and practical relevance. Through our experience and literature review, we provide insights and a practical roadmap for radiologists to navigate the complex landscape of AI in radiology. We aim to assist in making informed decisions that enhance diagnostic precision, improve patient outcomes, and streamline workflows, thus contributing to the advancement of radiological practices and patient care.

26 May 2025 in Diagnostics
Verified
Journal Article
Open access
PDF file
DADeniz Can Aliş
Deniz Can Aliş
AOAslihan Onay
Aslihan Onay
ECEvrim Colak
Evrim Colak
EKErcan Karaarslan
Ercan Karaarslan
BBBarış Bakır
Barış Bakır
Background/Objectives: Magnetic resonance imaging (MRI) is crucial in detecting suspicious lesions and diagnosing clinically significant prostate cancer (csPCa). However, variability in MRI-targeted diagnostic pathways arises due to factors such as patient characteristics, imaging protocols, and radiologist expertise. Artificial intelligence (AI) offers potential solutions to these challenges by enhancing diagnostic accuracy and efficiency. Methods: This narrative review explores AI techniques, particularly machine learning and deep learning, in the context of prostate cancer diagnosis. It examines their application in improving MRI scan quality, detecting artifacts, and assisting radiologists in lesion detection and interpretation. It also considers how AI helps to reduce reading time and inter-reader variability. Results: AI has demonstrated sensitivity that is generally comparable to experienced radiologists, although specificity tends to be lower, potentially increasing false-positive rates. The clinical impact of these results requires validation in larger, prospective multicenter studies. AI is effective in identifying artifacts, assessing MRI quality, and assisting in diagnostic efficiency by providing second opinions and automating lesion detection. However, variability in study methodologies, datasets, and imaging protocols can impact AI’s generalizability, limiting its broader clinical application. Conclusions: While AI shows significant promise in enhancing diagnostic accuracy and efficiency for csPCa detection, challenges remain, particularly with the generalizability of AI models. To improve AI robustness and integration into clinical practice, multicenter datasets and transparent reporting are essential. Further development, validation, and standardization are required for AI’s widespread clinical adoption.